Elke S. Bergmann‐Leitner

6.0k citations

89 papers · 3.9k indexed · 1 hit paper · h-index 30

Immunology top 2%
- Immunotherapy and Immune Responses 19
- Complement system in diseases 11
- Immune Cell Function and Interaction 9
Clinical Biochemistry top 1%
Virology top 5%
- HIV Research and Treatment 14
Molecular Biology top 5%
- vaccines and immunoinformatics approaches 17
Public Health, Environmental and Occupational Health top 2%
- Malaria Research and Control 35
- Mosquito-borne diseases and control 24
Infectious Diseases
- SARS-CoV-2 and COVID-19 Research 8

Co-authors: Wolfgang W. Leitner Stephan Frank Brigitte Gaume Everett G. Robert Frédéric Catez Richard J. Youle Carolyn L. Smith Evelina Angov
Cited by: Immunology Clinical Biochemistry Virology
Partner nations: United States Austria United Kingdom

In The Last Decade

Elke S. Bergmann‐Leitner

86 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2001 The Role of Dynamin-Related Protein 1, a Mediator of Mitochondrial Fission, in Apoptosis

Peers

Countries citing papers authored by Elke S. Bergmann‐Leitner

Since Specialization

Citations

This map shows the geographic impact of Elke S. Bergmann‐Leitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke S. Bergmann‐Leitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke S. Bergmann‐Leitner more than expected).

Fields of papers citing papers by Elke S. Bergmann‐Leitner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke S. Bergmann‐Leitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke S. Bergmann‐Leitner. The network helps show where Elke S. Bergmann‐Leitner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elke S. Bergmann‐Leitner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elke S. Bergmann‐Leitner Line = papers co-authored together Elke S. Bergmann‐Leitner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a multiplex serological assay to detect immunoreactivity against a novel Bartonella species in military working dogs Fernanda Fortes de Araújo,Jennifer Safko,Jessica S. Bolton,Le Jiang,Edwin Cooper,Stephen G. Jenkins,Edward B. Breitschwerdt,Naomi Aronson,Elke S. Bergmann‐Leitner	2025	0
2	Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge DeAnna Friedman-Klabanoff,Andrea A. Berry,Mark A. Travassos,Mallory Shriver,Catherine Cox,Jessica Butts,Jordan Lundeen,Kathleen A. Strauss,Sudhaunshu Joshi,Biraj Shrestha,Annie X. Mo,Effie Nomicos,Gregory A. Deye,Jason A. Regules,Elke S. Bergmann‐Leitner,Marcela F. Pasetti,Matthew B. Laurens	2024	2
3	Novel antibody competition binding assay identifies distinct serological profiles associated with protection Jessica S. Bolton,Randall S. MacGill,Emily Locke,Jason A. Regules,Elke S. Bergmann‐Leitner	2023	6
4	Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection Cosette G. Schneider,Julien Fey,Xiaoyan Zou,Vincent R. Gerbasi,Tatyana Savransky,Carl A. Batt,Elke S. Bergmann‐Leitner,Evelina Angov	2022	6
5	Clinical and genomic characterization of hypervirulent Klebsiella pneumoniae (hvKp) infections via passive surveillance in Southern California, 2020–2022 Edwin Kamau,Elizabeth L. Ranson,Allison Tsan,Elke S. Bergmann‐Leitner,Omai B. Garner,Shangxin Yang	2022	17
6	Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies Jishnu Das,Jonathan K. Fallon,Timothy C. Yu,Ashlin R. Michell,Todd J. Suscovich,Caitlyn Linde,Harini Natarajan,Joshua A. Weiner,Margherita Coccia,Scott Gregory,Margaret E. Ackerman,Elke S. Bergmann‐Leitner,Laura Fontana,Sheetij Dutta,Douglas A. Lauffenburger,Erik Jongert,Ulrike Wille-Reece,Galit Alter	2021	19
7	Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial Liriye Kurtovic,Tanmaya Atre,Gaoqian Feng,Bruce D. Wines,Jo-Anne Chan,Michelle J. Boyle,Damien R. Drew,P. Mark Hogarth,Freya J. I. Fowkes,Elke S. Bergmann‐Leitner,James G. Beeson	2020	38
8	Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens C. E. Hall,Lisa M. Hagan,Elke S. Bergmann‐Leitner,Donna Tosh,Jason W. Bennett,Jason A. Regules,Ilin Chuang,Evelina Angov,Sheetij Dutta,Debasish Chattopadhyay,Anjali Yadava	2018	10
9	Miniaturized Growth Inhibition Assay to Assess the Anti-blood Stage Activity of Antibodies Elizabeth H. Duncan,Elke S. Bergmann‐Leitner	2015	5
10	Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei Elke S. Bergmann‐Leitner,Ryan M. Mease,Patricia De La Vega,Tatyana Savranskaya,Mark E. Polhemus,Christian F. Ockenhouse,Evelina Angov	2010	95
11	Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis Elke S. Bergmann‐Leitner,Wolfgang W. Leitner,Elizabeth H. Duncan,Tatyana Savranskaya,Evelina Angov	2009	16
12	Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults Arlene E. Dent,Elke S. Bergmann‐Leitner,Danny W. Wilson,Daniel J. Tisch,Rhonda Kimmel,John Vulule,Peter Odada Sumba,James G. Beeson,Evelina Angov,Ann M. Moormann,James W. Kazura	2008	60
13	MFG-E8/Lactadherin Promotes Tumor Growth in an Angiogenesis-Dependent Transgenic Mouse Model of Multistage Carcinogenesis Melanie Neutzner,Theresa Lopez,Feng Xu,Elke S. Bergmann‐Leitner,Wolfgang W. Leitner,Mark C. Udey	2007	80
14	Complement 3d: From molecular adjuvant to target of immune escape mechanisms Elke S. Bergmann‐Leitner,Wolfgang W. Leitner,George C. Tsokos	2006	42
15	Epidermal Growth Factor Receptor Signaling and the Invasive Phenotype of Ovarian Carcinoma Cells Özge Alper,Elke S. Bergmann‐Leitner,Teresa Bennett,Neville F. Hacker,Kurt Stromberg,William G. Stetler‐Stevenson	2001	125
16	Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8 + cytotoxic T lymphocytes Elke S. Bergmann‐Leitner,Scott I. Abrams	2001	75
17	Positive and Negative Consequences of Soluble Fas Ligand Produced by an Antigen-Specific CD4+ T Cell Response in Human Carcinoma Immune Interactions Elke S. Bergmann‐Leitner,Scott I. Abrams	2001	8
18	Differential Role of Fas/Fas Ligand Interactions in Cytolysis of Primary and Metastatic Colon Carcinoma Cell Lines by Human Antigen-Specific CD8+ CTL Elke S. Bergmann‐Leitner,Scott I. Abrams	2000	39
19	PRODUCTION OF CD4+ AND CD8+ T CELL LINES FROM PATIENTS VACCINATED WITH MUTATED RAS PEPTIDES Scott I. Abrams,Samir N. Khleif,Elke S. Bergmann‐Leitner,J Schlom	1996	1
20	Immunoarchitecture and Specific Functions of Splenic Autotransplants at Different Implantation Sites Joseph Thalhamer,Wolfgang W. Leitner,Marion Kurz,Andrea Liaunigg,M Seifriedsberger,Elke S. Bergmann‐Leitner,H. Kaindl,W. Pimpi	1992	17

About Elke S. Bergmann‐Leitner

Elke S. Bergmann‐Leitner is a scholar working on Virology, Immunology and Public Health, Environmental and Occupational Health, having authored 89 papers that have together received 3.9k indexed citations. Recurring topics across this work include Malaria Research and Control (35 papers), Mosquito-borne diseases and control (24 papers), Immunotherapy and Immune Responses (19 papers), vaccines and immunoinformatics approaches (17 papers), HIV Research and Treatment (14 papers), Complement system in diseases (11 papers), Immune Cell Function and Interaction (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). The work is most often cited by research in Immunology (1.1k citations), Clinical Biochemistry (274 citations) and Virology (189 citations). Elke S. Bergmann‐Leitner has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Wolfgang W. Leitner, Stephan Frank, Brigitte Gaume, Everett G. Robert, Frédéric Catez, Richard J. Youle, Carolyn L. Smith, Evelina Angov, Scott I. Abrams and Elizabeth H. Duncan.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact